ALPK1 and leukemia: A recent paper has also linked the ADP-heptose-ALPK1 axis to ageing and expansion of rare leukemic cells, thus suggesting ALPK1 as a potential target to prevent progression of clonal haematopoiesis of indeterminate potential (CHIP) to overt leukemia and other related immune conditions14.